Literature DB >> 23081733

Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.

Aoife M Egan1, James Ryan, Mardiana A Aziz, Tadhg P O'Dwyer, Maria M Byrne.   

Abstract

We describe the clinical and genetic findings in pedigree with a novel mutation in the calcium sensing receptor (CaSR) gene and the unusual coexistence of primary hyperparathyroidism (HPT) and familial hypocalciuric hypercalcaemia (FHH) and its clinical management. The occurrence of both FHH and primary HPT in the same patient has been described rarely. Our pedigree has a novel mutation in the CaSR gene. Parathyroidectomy led to a reduction, but not normalization of the calcium levels in the patient identified as having HPT. The coexistence of HPT and FHH was considered in this patient as her calcium and PTH levels were rising with time. Surgical resection of her parathyroid adenoma resulted in reduction of her calcium levels to above normal and significant reduction in her symptoms of fatigue and low mood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23081733     DOI: 10.1007/s00774-012-0399-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  16 in total

Review 1.  Disorders of calcium homeostasis.

Authors:  Geert Carmeliet; Sophie Van Cromphaut; Evis Daci; Christa Maes; Roger Bouillon
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2003-12       Impact factor: 4.690

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.

Authors:  Lilia D'Souza-Li; Bing Yang; Lucie Canaff; Mei Bai; David A Hanley; Murat Bastepe; Sonia R Salisbury; Edward M Brown; David E C Cole; Geoffrey N Hendy
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality?

Authors:  K Burski; B Torjussen; A Q Paulsen; H Boman; J Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Nephrolithiasis and bone involvement in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; T P Jacobs; E S Siris; F Gartenberg; D Seldin; T L Clemens; J P Bilezikian
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

6.  The parathyroid glands in familial hypocalciuric hypercalcemia.

Authors:  U Thorgeirsson; J Costa; S J Marx
Journal:  Hum Pathol       Date:  1981-03       Impact factor: 3.466

Review 7.  Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.

Authors:  Leslie S Eldeiry; Daniel T Ruan; Edward M Brown; Jason L Gaglia; Jeffrey R Garber
Journal:  Endocr Pract       Date:  2012 May-Jun       Impact factor: 3.443

Review 8.  Diseases associated with the extracellular calcium-sensing receptor.

Authors:  R V Thakker
Journal:  Cell Calcium       Date:  2004-03       Impact factor: 6.817

9.  A patient with primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia induced by a novel germline CaSR gene mutation.

Authors:  Tomonori Yabuta; Akira Miyauchi; Hiroyuki Inoue; Hiroshi Yoshida; Mitsuyoshi Hirokawa; Nobuyuki Amino
Journal:  Asian J Surg       Date:  2009-04       Impact factor: 2.767

10.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

View more
  6 in total

1.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

2.  Parathyroid adenoma in a patient with familial hypocalciuric hypercalcaemia.

Authors:  Hannah Elizabeth Forde; Arnold D Hill; Diarmuid Smith
Journal:  BMJ Case Rep       Date:  2014-10-15

3.  Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.

Authors:  Silje Hovden; Marie Louise Jespersen; Peter H Nissen; Per Løgstrup Poulsen; Lars Rolighed; Søren A Ladefoged; Lars Rejnmark
Journal:  Clin Case Rep       Date:  2016-08-18

Review 4.  Diseases associated with calcium-sensing receptor.

Authors:  C Vahe; K Benomar; S Espiard; L Coppin; A Jannin; M F Odou; M C Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2017-01-25       Impact factor: 4.123

5.  Case Report: Familial Hypocalciuric Hypercalcaemia and Hashimoto's Thyroiditis.

Authors:  Shahd Mobarak; Munir Tarazi; Harry Spiers; Anjali Santhakumar; Bence Forgacs
Journal:  Front Surg       Date:  2020-06-16

6.  Case Report: Unusual Presentations of Loss-of-Function Mutations of the Calcium-Sensing Receptor.

Authors:  Serena Palmieri; Giorgia Grassi; Vito Guarnieri; Iacopo Chiodini; Maura Arosio; Cristina Eller-Vainicher
Journal:  Front Med (Lausanne)       Date:  2022-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.